Terms: = Liver cancer AND BTG1, P62324, 694, ENSG00000133639 AND Prognosis
29 results:
1. Effect of Behavioral Health Disorders on Surgical Outcomes in cancer Patients.
Katayama ES; Woldesenbet S; Munir MM; Endo Y; Rawicz-Pruszyński K; Khan MMM; Tsilimigras D; Dillhoff M; Cloyd J; Pawlik TM
J Am Coll Surg; 2024 Apr; 238(4):625-633. PubMed ID: 38420963
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma.
Wang XK; Guo YX; Wang M; Zhang XD; Liu ZY; Wang MS; Luo K; Huang S; Li RF
Sci Rep; 2023 Nov; 13(1):20969. PubMed ID: 38017264
[TBL] [Abstract] [Full Text] [Related]
3. Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma.
Reincke M; Schultheiss M; Doppler M; Verloh N; Uller W; Sturm L; Thimme R; Goetz C; Bettinger D
Hepatol Commun; 2022 Nov; 6(11):3223-3233. PubMed ID: 36064940
[TBL] [Abstract] [Full Text] [Related]
4. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Ni HH; Yang XH; Yang CL; Zhang Q; Xu JX; Qi LN; Xiang BD
Biomed Res Int; 2022; 2022():7305953. PubMed ID: 35880030
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.
Du X; Bai H; Wang Z; Daun J; Liu Z; Xu J; Chang G; Zhu Y; Wang J
Thorac Cancer; 2022 May; 13(9):1289-1298. PubMed ID: 35347870
[TBL] [Abstract] [Full Text] [Related]
6. Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus.
Lyu T; Yao H; Wang J; Song L; Tong X; Zou Y
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101819. PubMed ID: 34619365
[TBL] [Abstract] [Full Text] [Related]
7. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
[TBL] [Abstract] [Full Text] [Related]
8. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
[TBL] [Abstract] [Full Text] [Related]
9. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
Li J; Tian L; Jing Z; Guo Z; Nan P; Liu F; Zou S; Yang L; Xie X; Zhu Y; Zhao Y; Sun W; Sun Y; Zhao X
Cancer Lett; 2021 Sep; 516():13-27. PubMed ID: 34062216
[TBL] [Abstract] [Full Text] [Related]
10. Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients.
Chen CZ; Zhong JH; Qi YP; Zhang J; Huang T; Ma L; Li LQ; Peng T; Xiang BD
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835138
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.
Zhang YF; Wang YX; Zhang N; Lin ZH; Wang LR; Feng Y; Pan Q; Wang L
Bioengineered; 2021 Dec; 12(1):1202-1211. PubMed ID: 33830865
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract] [Full Text] [Related]
13. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts.
Tran A; Koh TS; Prawira A; Ho RZW; Le TBU; Vu TC; Hartano S; Teo XQ; Chen WC; Lee P; Thng CH; Huynh H
Mol Imaging Biol; 2021 Feb; 23(1):70-83. PubMed ID: 32909245
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
[TBL] [Abstract] [Full Text] [Related]
15. The aura of malignant tumor: Clinical analysis of malignant tumor-related pyogenic liver abscess.
Li W; Wu C; Qin M; Cai F; Huang J
Medicine (Baltimore); 2020 Feb; 99(9):e19282. PubMed ID: 32118740
[TBL] [Abstract] [Full Text] [Related]
16. Development and Validation of CAGIB Score for Evaluating the prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study.
Bai Z; Li B; Lin S; Liu B; Li Y; Zhu Q; Wu Y; Yang Y; Tang S; Meng F; Chen Y; Yuan S; Shao L; Qi X
Adv Ther; 2019 Nov; 36(11):3211-3220. PubMed ID: 31512140
[TBL] [Abstract] [Full Text] [Related]
17. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
[TBL] [Abstract] [Full Text] [Related]
18. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
[TBL] [Abstract] [Full Text] [Related]
19. Survival prediction among patients with non-cancer-related end-stage liver disease.
Tsai YW; Tzeng IS; Chen YC; Hsieh TH; Chang SS
PLoS One; 2018; 13(9):e0202692. PubMed ID: 30240398
[TBL] [Abstract] [Full Text] [Related]
20. Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France.
Hurtaud A; Donnadieu A; Escalup L; Cottu PH; Baffert S
Breast; 2016 Dec; 30():73-79. PubMed ID: 27639032
[TBL] [Abstract] [Full Text] [Related]
[Next]
